Cases
CourtFilingsPetition dateMore filters
Case closed Jun 28, 2019
Aralez Pharmaceuticals US Inc. entered Chapter 11 on August 10, 2018 as part of a coordinated restructuring of the Aralez group, with affiliated debtors commencing cases in the Southern District of New York and the parent and Canadian affiliate pursuing parallel CCAA proceedings in Ontario. The permitted record does not identify a later confirmed plan, sale closing, or pending hearing, so the supportable posture is the case at its opening rather than a later milestone. Chapter 11 petitionDkt. 1
Updated Sep 4, 5:36 PM ET
Affidavit of Service of Andrew Vignali Regarding Post-Confirmation Quarterly Operating Report for the Period July 1, 2019 through September 30, 2019 (related document(s)745) filed by Prime Clerk LLC.
Dkt. 747 · Oct 22, 2019
Affidavit of Service of Alain B. Francoeur Regarding Chapter 11 Closing Report for Aralez Pharmaceuticals Us Inc. and its Affiliated Debtors (related document(s)744) Filed by Adam M. Adler on behalf of Prime Clerk LLC.
Dkt. 746 · Oct 18, 2019
Quarterly Operating Report for the Period July 1, 2019 through September 30, 2019 Filed by Paul V. Shalhoub on behalf of Aralez Pharmaceuticals US Inc., et al..
Dkt. 745 · Oct 17, 2019
Use with MCP to query this case from your own tools.
Record as of September 6, 2026. Docket entries and dates come from the court. Nothing on this page is AI-generated.